Tenon Medical, Inc. (TNON) Stock Forecast
TNON analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 2 analysts
- Price target
- $44.38 average of analyst targets
- Upside to target
- +1,543.5% from the latest close
- Next earnings
- November 12, 2026 EPS estimate $-5.62
- 52-week range
- $2.44 – $45.15
TNON analyst ratings
2 analystsNumber of analysts at each rating.
TNON price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
TNON earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$5.62 | −$5.62 | −$5.62 | −$14.00 | +59.9% | 1 |
| Current fiscal year (2026) | −$21.25 | −$21.25 | −$21.25 | −$59.50 | +64.3% | 1 |
| Next fiscal year (2027) | −$12.02 | −$17.50 | −$6.54 | −$21.25 | +43.4% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
TNON revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.4M | $1.4M | $1.4M | +22.0% | 1 |
| Current fiscal year (2026) | $5.8M | $5.8M | $5.8M | +46.9% | 1 |
| Next fiscal year (2027) | $9.5M | $7.4M | $11.6M | +64.0% | 2 |
TNON EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
TNON revenue: reported and forecast
TNON EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$6.30 | −$6.30 | −$6.30 | −$6.30 | −$5.62 | −10.8% | 1 up · 0 down |
| Current fiscal year (2026) | −$29.57 | −$29.57 | −$29.57 | −$29.57 | −$21.25 | −28.1% | 1 up · 0 down |
| Next fiscal year (2027) | −$21.18 | −$21.18 | −$21.18 | −$21.18 | −$12.02 | −43.2% | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
TNON earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; TNON beat in 8 of 12.
What analysts expect from TNON
2 analysts cover Tenon Medical; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $44.38, 1,543.5% above the latest close of $2.70. Analysts expect earnings of −$21.25 per share for 2026, +64.3% from a year earlier. For 2027 the average estimate is −$12.02 per share on revenue of $9.5 million. Tenon Medical beat the EPS estimate in 8 of the last 12 quarters.
Related: TNON income statement, TNON key metrics, TNON chart. See the TNON stock overview for the latest quote and news.
TNON forecast FAQ
What is Tenon Medical's price target?
The average analyst price target for Tenon Medical is $44.38, 1,543.5% above the latest close of $2.70.
Is Tenon Medical a buy, hold or sell?
Of 2 analysts covering Tenon Medical, 1 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Tenon Medical's EPS forecast?
Analysts forecast −$21.25 per share for 2026 (range −$21.25 to −$21.25); for 2027 the estimate is −$12.02.
What is Tenon Medical's revenue forecast?
The average revenue estimate for 2026 is $5.8 million, growth of 46.9%; for 2027 it is $9.5 million.
When does Tenon Medical report earnings?
Tenon Medical is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 after the market closes; the EPS estimate is $-5.62.
Does Tenon Medical usually beat earnings estimates?
Tenon Medical reported EPS at or above the analyst estimate in 8 of the last 12 quarters.